Healthcare Realty Trust Inc. (NYSE:HR) has earned an average recommendation of “Hold” from the eleven research firms that are covering the firm. Eight analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average twelve-month target price among brokers that have issued ratings on the stock in the last year is $32.33.
Several equities research analysts have recently issued reports on the company. Cantor Fitzgerald reiterated a “hold” rating on shares of Healthcare Realty Trust in a report on Friday, September 9th. Zacks Investment Research downgraded Healthcare Realty Trust from a “hold” rating to a “sell” rating in a research note on Tuesday, August 23rd. Wells Fargo & Co. reissued a “hold” rating on shares of Healthcare Realty Trust in a research note on Sunday, September 4th. Mizuho raised their price objective on Healthcare Realty Trust from $29.00 to $34.00 and gave the company a “neutral” rating in a research note on Monday, August 8th. Finally, BTIG Research started coverage on Healthcare Realty Trust in a research report on Thursday, August 25th. They issued a “neutral” rating on the stock.
Healthcare Realty Trust (NYSE:HR) traded up 0.82% during trading on Monday, hitting $29.66. The stock had a trading volume of 177,224 shares. The company’s 50-day moving average is $30.72 and its 200 day moving average is $33.27. The firm has a market cap of $3.44 billion, a PE ratio of 60.78 and a beta of 0.40. Healthcare Realty Trust has a 52 week low of $26.58 and a 52 week high of $36.60.
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, November 30th. Shareholders of record on Wednesday, November 16th will be given a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 4.08%. The ex-dividend date is Monday, November 14th. Healthcare Realty Trust’s dividend payout ratio is currently 240.00%.
In other Healthcare Realty Trust news, Director Nancy H. Agee purchased 1,100 shares of the company’s stock in a transaction on Tuesday, September 13th. The shares were bought at an average cost of $33.68 per share, with a total value of $37,048.00. Following the transaction, the director now directly owns 3,555 shares in the company, valued at approximately $119,732.40. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO David R. Emery purchased 72,000 shares of the company’s stock in a transaction on Thursday, November 10th. The stock was acquired at an average cost of $27.66 per share, for a total transaction of $1,991,520.00. The disclosure for this purchase can be found here. 1.65% of the stock is owned by company insiders.
A number of hedge funds and other institutional investors have recently modified their holdings of the company. Vanguard Group Inc. raised its stake in shares of Healthcare Realty Trust by 11.8% in the second quarter. Vanguard Group Inc. now owns 16,890,282 shares of the real estate investment trust’s stock valued at $590,991,000 after buying an additional 1,785,381 shares during the last quarter. Nuveen Asset Management LLC raised its stake in shares of Healthcare Realty Trust by 524.3% in the second quarter. Nuveen Asset Management LLC now owns 1,482,644 shares of the real estate investment trust’s stock valued at $51,878,000 after buying an additional 1,245,165 shares during the last quarter. Emerald Acquisition Ltd. purchased a new stake in shares of Healthcare Realty Trust during the second quarter valued at $36,045,000. Duff & Phelps Investment Management Co. purchased a new stake in shares of Healthcare Realty Trust during the second quarter valued at $35,011,000. Finally, Schroder Investment Management Group purchased a new stake in shares of Healthcare Realty Trust during the second quarter valued at $33,971,000.